{"gene":"TLR4","run_date":"2026-06-10T10:51:55","timeline":{"discoveries":[{"year":1998,"finding":"TLR4 (hToll) signals through the adaptor protein MyD88, which in turn activates the kinase IRAK and the TRAF6 protein to activate NF-κB; AP-1 activation differs from IL-1R signaling, establishing MyD88 as a general adaptor for the Toll/IL-1R family.","method":"Dominant-negative and overexpression constructs in cell transfection assays; epistasis between hToll, MyD88, IRAK, and TRAF6 measured by NF-κB reporter assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean epistasis/genetic dissection with multiple pathway components replicated across labs; foundational paper widely confirmed","pmids":["9734363"],"is_preprint":false},{"year":2002,"finding":"TLR4 was identified by positional cloning as the central component of the mammalian LPS receptor, establishing it as the endotoxin sensor responsible for LPS-induced innate immune signaling.","method":"Positional cloning in LPS-hyporesponsive mouse mutants; gene knockout studies","journal":"Current topics in microbiology and immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — positional cloning plus knockout corroboration, independently replicated across multiple laboratories","pmids":["12467247"],"is_preprint":false},{"year":2010,"finding":"TAK-242 (resatorvid) binds selectively to TLR4 at Cys747 in the intracellular domain and disrupts protein-protein interactions between TLR4 and its adaptor molecules TIRAP and TRAM, thereby inhibiting both MyD88-dependent (NF-κB) and TRIF-dependent (ISRE) signaling pathways.","method":"Co-immunoprecipitation in HEK293 cells overexpressing TLR4/MD-2 with TIRAP or TRAM; NF-κB and ISRE reporter assays; IRAK activation assay in RAW264.7 cells","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP combined with functional reporter assays and endogenous kinase activation measurement in a single rigorous study","pmids":["20881006"],"is_preprint":false},{"year":2006,"finding":"HMGB1 signals through TLR4 (and TLR2) to induce cytokine production; in primary macrophages from TLR4 and MyD88 knockout mice, HMGB1-induced TNF release is significantly reduced compared to wild-type controls, placing TLR4/MyD88 in the HMGB1 signaling pathway.","method":"Neutralizing anti-TLR4/TLR2 antibodies in human whole blood and primary macrophages; TNF/IL-8 cytokine measurements; knockout macrophages (TLR4-/-, MyD88-/-, TLR2-/-); TLR2/TLR4-transfected HEK293 cells","journal":"Shock (Augusta, Ga.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockout plus antibody blocking plus transfection, but differential results between cell types add complexity","pmids":["16878026"],"is_preprint":false},{"year":2009,"finding":"MyD88 associates with PI3K p85 via a YXXM motif in the MyD88 TIR domain; sustained interaction of the MyD88/PI3K complex with the TLR4 intracellular signaling platform negatively regulates TLR4 signaling. LPS-induced Akt phosphorylation is TLR4-dependent and MyD88-dependent.","method":"Co-immunoprecipitation of MyD88 variants (YXXM→YXXA, TIR-domain deletion, death-domain deletion) with p85, TLR4, and WT MyD88; Akt phosphorylation assays in wild-type vs. MyD88-/- macrophages","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP with structure-function mutagenesis in single lab, supported by knockout confirmation","pmids":["19289601"],"is_preprint":false},{"year":2010,"finding":"FoxO1 transcription factor binds to multiple enhancer-like elements within the Tlr4 gene itself and in Tlr4 pathway genes, promoting Tlr4 expression and macrophage inflammatory signaling; TLR4 activation in turn induces AKT which inactivates FoxO1, establishing a self-limiting inflammatory loop.","method":"ChIP-Seq to identify FoxO1 binding sites; FoxO1 knockout/knockdown macrophage studies; reporter and cytokine secretion assays","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-Seq plus functional KO/KD with cytokine readouts in single lab","pmids":["21045807"],"is_preprint":false},{"year":2011,"finding":"TLR4 initiates distinct signaling pathways depending on cellular location: at the plasma membrane, bridging factor Mal recruits MyD88 leading to proinflammatory cytokine production; upon internalization into endosomes, TLR4 uses TRAM as a bridging factor to activate the MyD88-independent/TRIF pathway leading to type I interferon expression.","method":"Analysis of crystal structure data (TLR3-dsRNA complex used as model), combined with published biochemical and cell biology evidence reviewed and synthesized; pH-sensitivity experiments and adaptor localization data","journal":"Trends in biochemical sciences","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — mechanistic model integrating published structural and cell biology data; the TLR4 dual-location signaling mechanism itself is supported by multiple independent studies cited herein","pmids":["22196451"],"is_preprint":false},{"year":2012,"finding":"HMGB1 acts via TLR4 (but not RAGE) to accelerate muscle fatigue by impairing sarcoplasmic reticulum Ca2+ release in skeletal muscle fibers; signaling requires HMGB1 with a reduced Cys106 and a disulfide bond between Cys23 and Cys45.","method":"Single intact muscle fiber preparations from wild-type, TLR4-/-, and RAGE-/- mice; Ca2+ measurements during tetanic contractions; recombinant HMGB1 with defined redox states; immunofluorescence and confocal microscopy for TLR4 and MHC-I co-expression","journal":"Annals of the rheumatic diseases","confidence":"High","confidence_rationale":"Tier 2 / Strong — TLR4-/- vs. RAGE-/- genetic dissection with quantitative functional readout plus redox-state requirement of ligand defined in single rigorous study","pmids":["23148306"],"is_preprint":false},{"year":2013,"finding":"The TLR4-MD-2 complex recognizes LPS in a cascade involving LBP and CD14; structural studies show how the TLR4/MD-2 complex forms a 2:2:2 (TLR4:MD-2:LPS) activated homodimer, with Arg241 of TLR4 and Tyr102, Ser120, Lys122 of MD-2 important for antagonist binding.","method":"Crystal structure analysis of TLR4/MD-2/LPS complexes; structural basis reviewed from published crystal structures","journal":"Experimental & molecular medicine","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with structural validation of key residues; independently replicated in multiple structural labs","pmids":["24310172"],"is_preprint":false},{"year":2013,"finding":"A synthetic monosaccharide lipid A mimetic (compound 3) directly binds the MD-2 co-receptor (confirmed by NMR and molecular modeling) and also interacts with CD14, stimulating its internalization; dual targeting of MD-2 and CD14 inhibits TLR4 signaling, with greater effect at low LPS concentration when CD14 is important.","method":"NMR spectroscopy of compound-MD-2 interaction; molecular modeling/docking; CD14 internalization assay; TLR4 signaling inhibition in HEK-blue cells and murine macrophages","journal":"Chembiochem : a European journal of chemical biology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — NMR-confirmed binding plus functional cell assays in single lab","pmids":["24339336"],"is_preprint":false},{"year":1999,"finding":"Constitutively active TLR4 (CD4/hTLR4 chimera) activates an NF-κB reporter in cardiac myocytes but does not activate AP-1 or iNOS reporter constructs; TLR4 expression in cardiac myocytes is enhanced by LPS or IL-1β, an effect inhibited by the antioxidant PDTC.","method":"Transfection of constitutively active TLR4 construct with NF-κB, AP-1, and iNOS reporter constructs in cardiac myocytes; LPS/IL-1β stimulation; PDTC inhibition","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assays with constitutively active construct, clean negative results for AP-1/iNOS, pharmacological inhibition","pmids":["10430608"],"is_preprint":false},{"year":2020,"finding":"TLR4 activation promotes cardiomyocyte apoptosis through a pathway involving decreased SIRT2 expression, increased p53 acetylation, and activation of caspase-7 and caspase-9; TLR4 overexpression in H9c2 cells recapitulates nuclear p53 translocation and mitochondrial dysfunction.","method":"LPS treatment of rats (osmotic pump) and H9c2 cells; TLR4 and SIRT2 cDNA overexpression; Western blotting for p53 acetylation, cleaved caspase-7/caspase-9; mitochondrial complex activity assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo and in vitro corroboration with overexpression and pathway protein measurements, single lab","pmids":["33159115"],"is_preprint":false},{"year":2020,"finding":"During TLR4 signaling, necrosome activation in macrophages is mediated through both MyD88 and TRIF adaptor proteins and is inhibited by MK2; the RNA-binding protein tristetraprolin (TTP/ZFP36) inhibits TNFα/JNK-induced necrosome signaling during tonic TLR4 stimulation, preventing necroptosis.","method":"LPS stimulation of macrophages from WT, MyD88-/-, Trif-/-, MyD88-/-Trif-/-, MK2-/-, and Zfp36-/- mice; immunoblotting for necrosome components; ELISA for cytokines; cell death assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic knockouts with orthogonal readouts (necrosome, cytokine, cell death) in systematic comparison","pmids":["32094226"],"is_preprint":false},{"year":2020,"finding":"TLR4 activation by LPS abolishes cAMP-induced UCP1 upregulation in primary human adipocytes via endoplasmic reticulum stress; silencing of CHOP (a downstream ER stress mediator) or chemical chaperone treatment reverses LPS-induced suppression of adaptive thermogenesis, placing TLR4 upstream of ER stress/CHOP in suppressing UCP1 expression.","method":"LPS and high-fat diet treatment in vivo; siRNA-mediated TLR4 silencing; CHOP knockout mice; chemical chaperone treatment; UCP1 expression assays in primary human adipocytes","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic (CHOP KO, TLR4 siRNA) plus pharmacological intervention with functional thermogenesis readout, single lab","pmids":["26370079"],"is_preprint":false},{"year":2020,"finding":"uPAR (urokinase receptor) is a component of the TLR4 interactome; uPAR co-localizes and interacts with TLR4 on the cell membrane along with scavenger receptor CD36; downregulation of uPAR diminishes LPS-induced TLR4 signaling and NF-κB activation in myeloid and non-myeloid cells, and uPAR-/- mice show reduced inflammatory response in polymicrobial sepsis.","method":"Co-localization and co-immunoprecipitation of uPAR with TLR4 and CD36; uPAR knockdown in vitro; uPAR-/- mice in cecal ligation and puncture sepsis model; NFκB activation and cytokine assays","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP binding evidence plus in vivo KO confirmation, single lab","pmids":["33362762"],"is_preprint":false},{"year":2019,"finding":"In nociceptors, TLR4 mediates opioid-induced hyperalgesia (OIH) and hyperalgesic priming induced by low-dose morphine; antisense knockdown of TLR4 in nociceptors prevented OIH and priming; this mechanism requires PKCε signaling downstream of TLR4. High-dose morphine-induced analgesia and priming are TLR4-independent.","method":"Intrathecal antisense oligodeoxynucleotide (AS-ODN) to TLR4 mRNA; PKCε AS-ODN; saporin-based nociceptor depletion; nociceptive threshold measurements in rats","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — antisense knockdown with clean nociceptive functional readout, multiple negative controls confirming specificity","pmids":["31209174"],"is_preprint":false},{"year":2010,"finding":"TLR4 activation by LPS in macrophages causes significant subcellular lipidome remodeling across multiple organelles: ceramide and cholesterol precursors (desmosterol, lanosterol) increase in all compartments; oxidized sterols increase and unsaturated cardiolipins decrease in mitochondria; unsaturated ether-linked phosphatidylethanolamines decrease in the ER.","method":"Subcellular fractionation (nuclei, mitochondria, ER, plasmalemma, cytoplasm) of RAW264.7 macrophages; liquid chromatography/tandem mass spectrometry lipidomics of 229 lipid species","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic organelle fractionation with quantitative lipidomics, single lab","pmids":["20574076"],"is_preprint":false},{"year":2016,"finding":"TLR4 and MyD88 expressed on peritoneal B1a B cells are required for their natural IgM secretion and atheroprotective function; adoptive transfer of TLR4-/- or MyD88-/- B1a cells failed to suppress atherosclerosis, reduce lesion apoptotic cells, or modulate T-cell infiltrates in ApoE-/- mice.","method":"Adoptive transfer of WT, TLR4-/-, TLR2-/-, TLR9-/-, or MyD88-/- B1a cells into splenectomized ApoE-/- mice fed high-fat diet; atherosclerosis quantification; IgM ELISA; immunohistochemistry of lesions","journal":"Journal of the American Heart Association","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic dissection with adoptive transfer and multiple functional endpoints, single lab","pmids":["27930350"],"is_preprint":false},{"year":2018,"finding":"Adsorbed fibrinogen interacts with TLR4 on human monocytes, triggering ERK1/2 and JNK MAPK activation (but not p38) and inducing BMP-2 production; pharmacological TLR4 inhibition reduces both ERK/JNK phosphorylation and BMP-2 expression, establishing TLR4 as the upstream receptor for this pro-osteogenic pathway.","method":"Flow cytometry for TLR4 cell surface expression; Western blot for MAPK phosphorylation; specific TLR4 pharmacological inhibitor; BMP-2 mRNA and protein measurement in primary human monocytes on fibrinogen-coated chitosan substrates","journal":"Acta biomaterialia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological inhibition with multiple downstream readouts, single lab","pmids":["27856281"],"is_preprint":false},{"year":2021,"finding":"LPS/TLR4 signaling regulates osteoclastogenesis independent of the RANKL/RANK/OPG axis; TLR4 inhibitor TAK-242 blocks LPS-induced osteoclast differentiation and TNF-α secretion, and the pathway operates through LPS/TLR4/TNF-α/TNFR-2 autocrine/paracrine signaling.","method":"RAW264.7 differentiation assays; TAK-242 TLR4 inhibition; anti-TNF-α antibody blocking; membrane TLR4 and TNFR-2 level measurement; RANKL-primed then LPS-treated experimental design","journal":"BMC immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological inhibition plus antibody blocking with functional osteoclast differentiation and cytokine readouts, single lab","pmids":["33765924"],"is_preprint":false},{"year":2019,"finding":"TLR4 mediates acute heme-induced renal vasoconstriction; heme activates NF-κB and MCP-1 expression in renal epithelial cells via TLR4 signaling (blocked by TAK-242), but TLR4 does not mediate the anti-inflammatory Nrf2/HO-1 response to heme and does not mediate major mechanisms of glycerol-induced heme protein AKI.","method":"TAK-242 TLR4 antagonist in vivo; TLR4+/+ vs. TLR4-/- mice; renal blood flow measurement; NF-κB and Nrf2 reporter assays in renal epithelial cells; glycerol AKI model","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO plus pharmacological inhibition with multiple endpoints, important positive and negative findings dissected","pmids":["28978536"],"is_preprint":false},{"year":2005,"finding":"TLR4 is required for in vivo trapping of activated CD8+ T cells in the liver; in TLR4-deficient mice, the liver is compromised in its ability to sequester activated CD8+ T cells, revealing a role for basal TLR4 signaling by commensal LPS in regulating T cell distribution.","method":"TLR4-deficient mice (basal conditions, no exogenous inflammation); flow cytometry quantification of activated CD8+ T cells in liver vs. circulation; correlation analysis","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean in vivo genetic loss-of-function with defined cellular phenotype, single lab","pmids":["16034104"],"is_preprint":false},{"year":2010,"finding":"TLR4 activation induces B1 bradykinin receptor (B1R) expression in cardiac fibroblasts via upregulation of B1R mRNA and protein; LPS-primed cardiac fibroblasts show enhanced DAKD (B1R agonist)-induced PGI2 secretion and NO production and reduced collagen I levels, revealing TLR4-B1R crosstalk in cardiac inflammation.","method":"qRT-PCR and Western blot for B1R, COX-2, iNOS in primary human, rat, and mouse cardiac fibroblasts; LPS pretreatment; DAKD stimulation; PGI2 and NO measurement","journal":"Toxicology and applied pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multi-species corroboration with functional signaling readouts, single lab","pmids":["29775649"],"is_preprint":false},{"year":2007,"finding":"TLR4 ligand (LPS/Kdo2-lipid A) synergizes with sustained Ca2+ influx to activate the 5-lipoxygenase (5-LO) eicosanoid pathway in macrophages, independent of NF-κB-mediated protein synthesis; COX metabolite profiles are unaffected by TLR stimulation alone.","method":"LC/MS-MS quantification of >60 eicosanoids in RAW264.7 macrophages stimulated with 16 agonists; NF-κB inhibition to dissect protein synthesis-dependent vs. -independent pathways; Ca2+ influx manipulation","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — quantitative mass spectrometry-based eicosanoid profiling with pharmacological dissection, single lab","pmids":["17535806"],"is_preprint":false},{"year":2010,"finding":"TLR4 mediates anti-β2GPI/β2GPI-induced tissue factor (TF) expression in THP-1 monocytic cells; both TLR4 and annexin A2 (ANX2) can bind β2GPI, and ANX2-RNAi knockdown diminishes TLR4, MD-2, MyD88, and TF expression in response to the complex, revealing cooperative ANX2-TLR4 signaling.","method":"β2GPI affinity column pulldown showing TLR4 and ANX2 binding; ANX2-specific RNAi lentivirus knockdown; Western blot for TLR4/MD-2/MyD88/TF; paclitaxel competition with MD-2 ligand","journal":"Clinical and experimental immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pulldown binding plus RNAi loss-of-function with downstream signaling readouts, single lab","pmids":["21091668"],"is_preprint":false},{"year":2019,"finding":"TLR4-dependent activation of the JNK signaling pathway promotes APAP-induced liver inflammation; TLR4-/- mice show attenuated JNK phosphorylation, reduced inflammatory cytokines, and less macrophage/neutrophil infiltration after acetaminophen challenge; TLR4 siRNA in RAW264.7 cells similarly inhibits JNK and p38 phosphorylation.","method":"TLR4-/- vs. WT mice treated with APAP; liver histology, ALT/GSH measurement; RT-qPCR and ELISA for cytokines; Western blot for phospho-JNK and phospho-p38; flow cytometry for immune cell infiltration; TLR4-siRNA in RAW264.7","journal":"European review for medical and pharmacological sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with in vitro siRNA corroboration and multiple signaling readouts, single lab","pmids":["31539158"],"is_preprint":false}],"current_model":"TLR4 functions as a transmembrane pattern-recognition receptor that detects LPS and other danger-associated ligands by forming a complex with the co-receptor MD-2 and accessory proteins CD14 and LBP, leading to an activated (TLR4:MD-2:LPS)2 homodimer; at the plasma membrane TLR4 recruits the bridging adaptor Mal to engage MyD88, activating IRAK and TRAF6 to drive NF-κB and MAPK signaling, while after endosomal internalization it switches to TRAM-dependent TRIF signaling to induce type I interferons; the small-molecule TAK-242 binds Cys747 in the intracellular domain and disrupts TLR4–TIRAP and TLR4–TRAM interactions; PI3K/p85 associates with the MyD88 YXXM motif and negatively regulates signaling; TLR4 also couples to additional interactors including uPAR/CD36, and activates cell-type-specific downstream effectors including JNK, PKCε, SIRT2/p53, and ER stress/CHOP to mediate inflammation, apoptosis, and thermogenesis suppression."},"narrative":{"mechanistic_narrative":"TLR4 is the central transmembrane pattern-recognition receptor of the mammalian innate immune system, identified by positional cloning as the sensor responsible for LPS-induced signaling [PMID:12467247]. Ligand detection occurs through the TLR4–MD-2 co-receptor complex, which recognizes LPS in a cascade involving LBP and CD14 and assembles into an activated 2:2:2 (TLR4:MD-2:LPS) homodimer, with defined residues governing agonist/antagonist binding [PMID:24310172, PMID:24339336]. Once engaged, TLR4 signals through bifurcated, location-dependent adaptor circuitry: at the plasma membrane the bridging factor Mal recruits MyD88 to activate IRAK and TRAF6, driving NF-κB activation, whereas upon endosomal internalization TLR4 switches to a TRAM-bridged, MyD88-independent TRIF pathway to induce type I interferons [PMID:9734363, PMID:22196451]. This adaptor logic is targetable: the small molecule TAK-242 binds Cys747 in the TLR4 intracellular domain and disrupts both the TLR4–TIRAP and TLR4–TRAM interactions, blocking MyD88- and TRIF-dependent outputs [PMID:20881006], and signaling is intrinsically restrained by a MyD88–PI3K(p85) complex docking on the YXXM motif of MyD88 [PMID:19289601] and by a FoxO1–AKT feedback loop that controls Tlr4 transcription [PMID:21045807]. Beyond endotoxin, TLR4 senses endogenous danger ligands including HMGB1 (in a redox-state-dependent manner) and fibrinogen, and cooperates with accessory partners such as uPAR/CD36 and annexin A2 to amplify inflammatory responses [PMID:16878026, PMID:23148306, PMID:33362762, PMID:27856281, PMID:21091668]. Downstream of these inputs TLR4 engages cell-type-specific effectors—JNK/p38 MAPK in hepatic and monocytic inflammation [PMID:27856281, PMID:31539158], necrosome assembly via both MyD88 and TRIF [PMID:32094226], a SIRT2/p53/caspase apoptotic axis in cardiomyocytes [PMID:33159115], and ER stress/CHOP signaling that suppresses adaptive thermogenesis [PMID:26370079]—thereby mediating inflammation, programmed cell death, and metabolic adaptation across diverse tissues.","teleology":[{"year":1998,"claim":"Established the core adaptor logic of TLR4 by placing MyD88, IRAK, and TRAF6 downstream of the receptor, defining how an innate receptor converts ligand sensing into NF-κB activation.","evidence":"Dominant-negative and overexpression epistasis with NF-κB reporters in transfected cells","pmids":["9734363"],"confidence":"High","gaps":["Did not identify the physiological ligand","AP-1 activation mechanism left distinct from IL-1R but undefined"]},{"year":2002,"claim":"Identified TLR4 itself as the LPS receptor, answering what molecule senses endotoxin and anchoring TLR4 as the endotoxin sensor of innate immunity.","evidence":"Positional cloning of LPS-hyporesponsive mouse mutants plus knockout corroboration","pmids":["12467247"],"confidence":"High","gaps":["Did not resolve the structural basis of LPS recognition","Role of co-receptors not defined here"]},{"year":2005,"claim":"Revealed a homeostatic, non-inflammatory role for basal TLR4 signaling by commensal LPS in distributing activated T cells, broadening TLR4 function beyond acute pathogen response.","evidence":"TLR4-deficient mice under basal conditions with flow-cytometric quantification of hepatic CD8+ T-cell trapping","pmids":["16034104"],"confidence":"Medium","gaps":["Adaptor/effector pathway for T-cell trapping unidentified","Single phenotype, single lab"]},{"year":2006,"claim":"Extended TLR4 ligand recognition to the endogenous danger signal HMGB1, establishing TLR4/MyD88 as a sensor of sterile injury, not only microbial LPS.","evidence":"Knockout macrophages, neutralizing antibodies, and transfected HEK293 cells with cytokine readouts","pmids":["16878026"],"confidence":"Medium","gaps":["Differential results between cell types complicate interpretation","Direct HMGB1–TLR4 binding not demonstrated here"]},{"year":2007,"claim":"Showed TLR4 can drive lipid-mediator (5-LO eicosanoid) output independently of NF-κB-driven protein synthesis when combined with Ca2+ influx, revealing a transcription-independent arm of TLR4 signaling.","evidence":"LC/MS-MS eicosanoid profiling with NF-κB inhibition and Ca2+ manipulation in RAW264.7 macrophages","pmids":["17535806"],"confidence":"Medium","gaps":["Molecular link from TLR4 to 5-LO activation unmapped","Requires synergistic Ca2+ signal of undefined source"]},{"year":2009,"claim":"Defined a built-in negative-regulatory mechanism whereby a MyD88–PI3K(p85) complex docks via the MyD88 YXXM motif to restrain TLR4 output, addressing how signaling is self-limited.","evidence":"Reciprocal Co-IP with MyD88 structure-function mutants plus Akt phosphorylation in MyD88-/- macrophages","pmids":["19289601"],"confidence":"Medium","gaps":["Quantitative contribution to signal damping in vivo unclear","Single lab"]},{"year":2010,"claim":"Resolved how a single inhibitor blocks both TLR4 outputs: TAK-242 binds Cys747 and disrupts TLR4–TIRAP and TLR4–TRAM interactions, pinpointing an intracellular druggable site.","evidence":"Reciprocal Co-IP in HEK293, NF-κB/ISRE reporters, and IRAK activation in RAW264.7","pmids":["20881006"],"confidence":"High","gaps":["Structural detail of the Cys747 binding pocket not solved here","Selectivity across TLR family not fully mapped"]},{"year":2010,"claim":"Identified a transcriptional feed-forward/feedback loop in which FoxO1 promotes Tlr4 expression while TLR4-induced AKT inactivates FoxO1, explaining self-limiting macrophage inflammation.","evidence":"ChIP-Seq of FoxO1 binding plus FoxO1 KO/KD macrophage cytokine assays","pmids":["21045807"],"confidence":"Medium","gaps":["Direct demonstration of loop dynamics in vivo limited","Single lab"]},{"year":2011,"claim":"Articulated the spatial bifurcation of TLR4 signaling—Mal/MyD88 at the membrane versus TRAM/TRIF in endosomes—explaining how one receptor produces both cytokines and type I interferons.","evidence":"Synthesis of structural and cell-biology data including adaptor localization and pH-sensitivity","pmids":["22196451"],"confidence":"Medium","gaps":["Integrative model rather than single primary dataset","Trafficking machinery driving the switch not detailed here"]},{"year":2013,"claim":"Provided the structural mechanism of LPS recognition, showing the TLR4/MD-2/LPS 2:2:2 activated homodimer and the residues governing agonist/antagonist binding.","evidence":"Crystal structure analysis of TLR4/MD-2/LPS complexes","pmids":["24310172"],"confidence":"High","gaps":["Dynamics of dimerization in membranes not captured","Co-receptor CD14/LBP handoff geometry not resolved"]},{"year":2013,"claim":"Demonstrated druggable dual targeting of the recognition module by a lipid A mimetic that binds MD-2 and engages CD14, defining co-receptor-level antagonism.","evidence":"NMR of compound–MD-2 binding, docking, CD14 internalization, and TLR4 signaling inhibition in HEK-blue and macrophages","pmids":["24339336"],"confidence":"Medium","gaps":["In vivo efficacy not established","Single lab"]},{"year":2012,"claim":"Linked redox-defined HMGB1 to TLR4 in a non-immune tissue, showing TLR4 (not RAGE) drives muscle fatigue via impaired SR Ca2+ release, expanding TLR4 effector outputs beyond cytokines.","evidence":"Single intact muscle fibers from TLR4-/- vs. RAGE-/- mice with Ca2+ measurements and defined HMGB1 redox states","pmids":["23148306"],"confidence":"High","gaps":["Intracellular pathway from TLR4 to SR Ca2+ handling unmapped","Adaptor usage in muscle not defined"]},{"year":2020,"claim":"Defined how TLR4 controls regulated necroptosis, showing necrosome activation through both MyD88 and TRIF and its restraint by MK2 and the RNA-binding protein TTP/ZFP36.","evidence":"LPS stimulation across WT, MyD88-/-, Trif-/-, double-KO, MK2-/-, and Zfp36-/- macrophages with necrosome, cytokine, and cell-death readouts","pmids":["32094226"],"confidence":"High","gaps":["Precise molecular target of TTP within the necrosome pathway not pinpointed","Relevance in vivo not tested here"]},{"year":2020,"claim":"Connected TLR4 to metabolic suppression of thermogenesis, placing TLR4 upstream of ER stress/CHOP in blocking cAMP-induced UCP1 in adipocytes.","evidence":"LPS/HFD in vivo, TLR4 siRNA, CHOP KO mice, and chemical chaperone with UCP1 readouts","pmids":["26370079"],"confidence":"Medium","gaps":["Adaptor route from TLR4 to ER stress not defined","Single lab"]},{"year":2020,"claim":"Identified a TLR4-driven apoptotic axis in cardiomyocytes operating through SIRT2 loss, p53 acetylation, and caspase activation, defining a cell-death effector branch.","evidence":"LPS in rats and H9c2 cells with TLR4/SIRT2 overexpression and pathway protein blotting","pmids":["33159115"],"confidence":"Medium","gaps":["Link between TLR4 proximal signaling and SIRT2 regulation unmapped","Single lab"]},{"year":2020,"claim":"Placed uPAR (with CD36) in the TLR4 membrane interactome as a positive regulator of LPS-induced NF-κB signaling and sepsis inflammation.","evidence":"Co-localization/Co-IP of uPAR with TLR4 and CD36, uPAR knockdown, and uPAR-/- mice in CLP sepsis","pmids":["33362762"],"confidence":"Medium","gaps":["Direct binding interface not defined","Mechanism of signal enhancement unclear"]},{"year":2010,"claim":"Showed TLR4 cooperates with annexin A2 to sense the anti-β2GPI/β2GPI complex and drive tissue factor expression, expanding the receptor's prothrombotic ligand repertoire.","evidence":"β2GPI affinity pulldown of TLR4 and ANX2 with ANX2-RNAi and TLR4/MD-2/MyD88/TF blotting in THP-1 cells","pmids":["21091668"],"confidence":"Medium","gaps":["Stoichiometry of TLR4–ANX2 cooperation unknown","Single lab"]},{"year":2010,"claim":"Mapped TLR4-induced organelle-resolved lipidome remodeling, revealing that activation reshapes sterol, ceramide, cardiolipin, and ether-lipid pools across compartments.","evidence":"Subcellular fractionation and LC-MS/MS lipidomics of 229 species in RAW264.7 macrophages","pmids":["20574076"],"confidence":"Medium","gaps":["Causal signaling link from TLR4 to specific lipid changes not established","Functional consequence per organelle unclear"]},{"year":1999,"claim":"Showed in cardiac myocytes that constitutively active TLR4 activates NF-κB but not AP-1 or iNOS, demonstrating cell-type-specific selectivity of TLR4 transcriptional outputs.","evidence":"Constitutively active TLR4 chimera with NF-κB/AP-1/iNOS reporters and PDTC inhibition in cardiac myocytes","pmids":["10430608"],"confidence":"Medium","gaps":["Basis for restricted AP-1/iNOS activation undefined","Reliant on chimeric construct"]},{"year":2016,"claim":"Demonstrated a protective TLR4/MyD88 function in B1a B cells required for natural IgM secretion and atheroprotection, illustrating context-dependent beneficial roles.","evidence":"Adoptive transfer of WT vs. TLR4-/-/MyD88-/- B1a cells into ApoE-/- mice with lesion and IgM endpoints","pmids":["27930350"],"confidence":"Medium","gaps":["Ligand driving B1a TLR4 function unidentified","Single lab"]},{"year":2018,"claim":"Identified adsorbed fibrinogen as a TLR4 ligand on monocytes driving ERK/JNK MAPK activation and BMP-2 production, linking TLR4 to a pro-osteogenic response.","evidence":"Flow cytometry, MAPK phospho-blotting, TLR4 pharmacological inhibition, and BMP-2 measurement in human monocytes","pmids":["27856281"],"confidence":"Medium","gaps":["Direct fibrinogen–TLR4 binding not biochemically resolved","Single lab"]},{"year":2019,"claim":"Defined a TLR4/PKCε pathway in nociceptors mediating opioid-induced hyperalgesia and priming, distinguishing low-dose from high-dose morphine mechanisms.","evidence":"Intrathecal TLR4 and PKCε antisense oligonucleotides with nociceptive threshold readouts in rats","pmids":["31209174"],"confidence":"Medium","gaps":["Endogenous TLR4 ligand in OIH unidentified","Adaptor usage in nociceptors not defined"]},{"year":2019,"claim":"Showed TLR4 drives acetaminophen-induced liver inflammation via JNK activation, defining a MAPK effector branch in sterile hepatic injury.","evidence":"TLR4-/- vs. WT mice with histology, cytokine, and phospho-JNK/p38 readouts plus TLR4 siRNA in RAW264.7","pmids":["31539158"],"confidence":"Medium","gaps":["Proximal ligand/adaptor coupling to JNK not delineated","Single lab"]},{"year":2019,"claim":"Demonstrated TLR4 mediates acute heme-induced renal vasoconstriction and NF-κB/MCP-1 induction while sparing the Nrf2/HO-1 axis, dissecting which heme responses depend on TLR4.","evidence":"TAK-242 in vivo, TLR4-/- mice, renal blood flow, and NF-κB/Nrf2 reporters in renal epithelial cells","pmids":["28978536"],"confidence":"Medium","gaps":["Mechanism of heme engagement of TLR4 unresolved","Does not mediate glycerol-induced AKI"]},{"year":2010,"claim":"Showed TLR4 induces B1 bradykinin receptor expression in cardiac fibroblasts, revealing TLR4–B1R crosstalk modulating PGI2, NO, and collagen in cardiac inflammation.","evidence":"qRT-PCR/Western blot for B1R/COX-2/iNOS with LPS priming and DAKD stimulation across human, rat, and mouse fibroblasts","pmids":["29775649"],"confidence":"Medium","gaps":["Signaling route from TLR4 to B1R transcription unmapped","Single lab"]},{"year":null,"claim":"How the spatial adaptor switch is physically controlled by trafficking machinery, and how diverse endogenous ligands (HMGB1, fibrinogen, heme, β2GPI complexes) are differentially read to select cell-type-specific effector branches (JNK, SIRT2/p53, ER stress/CHOP, PKCε), remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified mechanism linking ligand identity to downstream effector selection","Trafficking determinants of the MyD88-to-TRIF switch not biochemically defined","Many tissue-specific effector branches rest on single-lab studies"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0001618","term_label":"virus receptor activity","supporting_discovery_ids":[1,8]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,1,8]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[8,9]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,10]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[6,14]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,1,8,12]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,2,6]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[11,12]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[13]}],"complexes":["TLR4:MD-2:LPS activated homodimer"],"partners":["MD2 (LY96)","CD14","MYD88","TIRAP","TRAM (TICAM2)","PIK3R1","UPAR (PLAUR)","CD36"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O00206","full_name":"Toll-like receptor 4","aliases":["hToll"],"length_aa":839,"mass_kda":95.7,"function":"Transmembrane receptor that functions as a pattern recognition receptor recognizing pathogen- and damage-associated molecular patterns (PAMPs and DAMPs) to induce innate immune responses via downstream signaling pathways (PubMed:10835634, PubMed:15809303, PubMed:16622205, PubMed:17292937, PubMed:17478729, PubMed:20037584, PubMed:20711192, PubMed:23880187, PubMed:27022195, PubMed:29038465, PubMed:17803912, PubMed:15852007). At the plasma membrane, cooperates with LY96 to mediate the innate immune response to bacterial lipopolysaccharide (LPS) (PubMed:27022195). Also involved in LPS-independent inflammatory responses triggered by free fatty acids, such as palmitate, and Ni(2+) (PubMed:20711192). Mechanistically, acts via MYD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (PubMed:10835634, PubMed:21393102, PubMed:27022195, PubMed:36945827, PubMed:9237759). Alternatively, CD14-mediated TLR4 internalization via endocytosis is associated with the initiation of a MYD88-independent signaling via the TICAM1-TBK1-IRF3 axis leading to type I interferon production (PubMed:14517278). In addition to the secretion of proinflammatory cytokines, initiates the activation of NLRP3 inflammasome and formation of a positive feedback loop between autophagy and NF-kappa-B signaling cascade (PubMed:32894580). In complex with TLR6, promotes inflammation in monocytes/macrophages by associating with TLR6 and the receptor CD86 (PubMed:23880187). Upon ligand binding, such as oxLDL or amyloid-beta 42, the TLR4:TLR6 complex is internalized and triggers inflammatory response, leading to NF-kappa-B-dependent production of CXCL1, CXCL2 and CCL9 cytokines, via MYD88 signaling pathway, and CCL5 cytokine, via TICAM1 signaling pathway (PubMed:23880187). In myeloid dendritic cells, vesicular stomatitis virus glycoprotein G but not LPS promotes the activation of IRF7, leading to type I IFN production in a CD14-dependent manner (PubMed:15265881, PubMed:23880187). Required for the migration-promoting effects of ZG16B/PAUF on pancreatic cancer cells","subcellular_location":"Cell membrane; Early endosome; Cell projection, ruffle","url":"https://www.uniprot.org/uniprotkb/O00206/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TLR4","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TLR4","total_profiled":1310},"omim":[{"mim_id":"621051","title":"PARALEMMIN 3; PALM3","url":"https://www.omim.org/entry/621051"},{"mim_id":"620997","title":"SEMAPHORIN 3G; SEMA3G","url":"https://www.omim.org/entry/620997"},{"mim_id":"620165","title":"LEUCINE-RICH REPEATS- AND CALPONIN HOMOLOGY DOMAIN-CONTAINING PROTEIN 4; LRCH4","url":"https://www.omim.org/entry/620165"},{"mim_id":"619990","title":"TRANSMEMBRANE p24 TRAFFICKING PROTEIN 7; TMED7","url":"https://www.omim.org/entry/619990"},{"mim_id":"619181","title":"FAMILY WITH SEQUENCE SIMILARITY 177, MEMBER A1; FAM177A1","url":"https://www.omim.org/entry/619181"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Golgi apparatus","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TLR4"},"hgnc":{"alias_symbol":["hToll","CD284","TLR-4","ARMD10"],"prev_symbol":[]},"alphafold":{"accession":"O00206","domains":[{"cath_id":"3.80.10.10","chopping":"28-133","consensus_level":"medium","plddt":96.7072,"start":28,"end":133},{"cath_id":"-","chopping":"139-154_166-177_191-323","consensus_level":"medium","plddt":94.9788,"start":139,"end":323},{"cath_id":"3.80.10.10","chopping":"475-630","consensus_level":"medium","plddt":93.1298,"start":475,"end":630},{"cath_id":"3.40.50.10140","chopping":"673-817","consensus_level":"high","plddt":85.222,"start":673,"end":817},{"cath_id":"2.160.20","chopping":"324-334_341-440","consensus_level":"medium","plddt":94.6293,"start":324,"end":440}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O00206","model_url":"https://alphafold.ebi.ac.uk/files/AF-O00206-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O00206-F1-predicted_aligned_error_v6.png","plddt_mean":89.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TLR4","jax_strain_url":"https://www.jax.org/strain/search?query=TLR4"},"sequence":{"accession":"O00206","fasta_url":"https://rest.uniprot.org/uniprotkb/O00206.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O00206/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O00206"}},"corpus_meta":[{"pmid":"9734363","id":"PMC_9734363","title":"MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.","date":"1998","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/9734363","citation_count":1233,"is_preprint":false},{"pmid":"24310172","id":"PMC_24310172","title":"Recognition of lipopolysaccharide pattern by TLR4 complexes.","date":"2013","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24310172","citation_count":979,"is_preprint":false},{"pmid":"16878026","id":"PMC_16878026","title":"HMGB1 signals through toll-like receptor (TLR) 4 and TLR2.","date":"2006","source":"Shock (Augusta, Ga.)","url":"https://pubmed.ncbi.nlm.nih.gov/16878026","citation_count":707,"is_preprint":false},{"pmid":"10430608","id":"PMC_10430608","title":"Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium.","date":"1999","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/10430608","citation_count":542,"is_preprint":false},{"pmid":"20881006","id":"PMC_20881006","title":"TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules.","date":"2010","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20881006","citation_count":510,"is_preprint":false},{"pmid":"16585214","id":"PMC_16585214","title":"TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16585214","citation_count":427,"is_preprint":false},{"pmid":"18535784","id":"PMC_18535784","title":"TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme.","date":"2008","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/18535784","citation_count":373,"is_preprint":false},{"pmid":"38001481","id":"PMC_38001481","title":"Toll-like receptor 4 (TLR4): new insight immune and aging.","date":"2023","source":"Immunity & ageing : I & A","url":"https://pubmed.ncbi.nlm.nih.gov/38001481","citation_count":307,"is_preprint":false},{"pmid":"33505220","id":"PMC_33505220","title":"COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation.","date":"2021","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/33505220","citation_count":285,"is_preprint":false},{"pmid":"19289601","id":"PMC_19289601","title":"TLR4/MyD88/PI3K interactions regulate TLR4 signaling.","date":"2009","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/19289601","citation_count":277,"is_preprint":false},{"pmid":"35307617","id":"PMC_35307617","title":"Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective.","date":"2022","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35307617","citation_count":250,"is_preprint":false},{"pmid":"17403033","id":"PMC_17403033","title":"Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury.","date":"2007","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17403033","citation_count":236,"is_preprint":false},{"pmid":"21045807","id":"PMC_21045807","title":"FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages.","date":"2010","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/21045807","citation_count":214,"is_preprint":false},{"pmid":"26113297","id":"PMC_26113297","title":"Hepatic TLR4 signaling in obese NAFLD.","date":"2015","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/26113297","citation_count":209,"is_preprint":false},{"pmid":"16371473","id":"PMC_16371473","title":"Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16371473","citation_count":205,"is_preprint":false},{"pmid":"12467247","id":"PMC_12467247","title":"TLR4 as the mammalian endotoxin sensor.","date":"2002","source":"Current topics in microbiology and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12467247","citation_count":196,"is_preprint":false},{"pmid":"20814545","id":"PMC_20814545","title":"TLR4 and Insulin Resistance.","date":"2010","source":"Gastroenterology research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/20814545","citation_count":180,"is_preprint":false},{"pmid":"20574076","id":"PMC_20574076","title":"Subcellular organelle lipidomics in TLR-4-activated macrophages.","date":"2010","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/20574076","citation_count":165,"is_preprint":false},{"pmid":"24188011","id":"PMC_24188011","title":"Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update.","date":"2013","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24188011","citation_count":147,"is_preprint":false},{"pmid":"21664961","id":"PMC_21664961","title":"Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists.","date":"2011","source":"Biotechnology advances","url":"https://pubmed.ncbi.nlm.nih.gov/21664961","citation_count":138,"is_preprint":false},{"pmid":"18486483","id":"PMC_18486483","title":"TLR-4 deficiency protects against focal cerebral ischemia and axotomy-induced neurodegeneration.","date":"2008","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/18486483","citation_count":132,"is_preprint":false},{"pmid":"22363498","id":"PMC_22363498","title":"Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22363498","citation_count":130,"is_preprint":false},{"pmid":"26743224","id":"PMC_26743224","title":"TLR-4 may mediate signaling pathways of Astragalus polysaccharide RAP induced cytokine expression of RAW264.7 cells.","date":"2015","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26743224","citation_count":121,"is_preprint":false},{"pmid":"25237008","id":"PMC_25237008","title":"Toll like receptor 4 (TLR4) mediates the stimulating activities of chitosan oligosaccharide on macrophages.","date":"2014","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25237008","citation_count":108,"is_preprint":false},{"pmid":"28330785","id":"PMC_28330785","title":"The interplay between Angiotensin II, TLR4 and hypertension.","date":"2017","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/28330785","citation_count":103,"is_preprint":false},{"pmid":"24235843","id":"PMC_24235843","title":"Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers.","date":"2013","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/24235843","citation_count":99,"is_preprint":false},{"pmid":"26370079","id":"PMC_26370079","title":"Activation of Toll-like receptor 4 (TLR4) attenuates adaptive thermogenesis via endoplasmic reticulum stress.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26370079","citation_count":95,"is_preprint":false},{"pmid":"23071493","id":"PMC_23071493","title":"TLR-4 signalling accelerates colon cancer cell adhesion via NF-κB mediated transcriptional up-regulation of Nox-1.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23071493","citation_count":92,"is_preprint":false},{"pmid":"17535806","id":"PMC_17535806","title":"TLR-4 and sustained calcium agonists synergistically produce eicosanoids independent of protein synthesis in RAW264.7 cells.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17535806","citation_count":84,"is_preprint":false},{"pmid":"23148306","id":"PMC_23148306","title":"TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis.","date":"2012","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/23148306","citation_count":80,"is_preprint":false},{"pmid":"33765924","id":"PMC_33765924","title":"Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling.","date":"2021","source":"BMC immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33765924","citation_count":78,"is_preprint":false},{"pmid":"19888805","id":"PMC_19888805","title":"TLR-2, TLR-4 and dectin-1 expression in human monocytes and neutrophils stimulated by Paracoccidioides brasiliensis.","date":"2009","source":"Medical mycology","url":"https://pubmed.ncbi.nlm.nih.gov/19888805","citation_count":72,"is_preprint":false},{"pmid":"33666891","id":"PMC_33666891","title":"Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation.","date":"2021","source":"Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/33666891","citation_count":71,"is_preprint":false},{"pmid":"33159115","id":"PMC_33159115","title":"Activation of toll like receptor 4 (TLR4) promotes cardiomyocyte apoptosis through SIRT2 dependent p53 deacetylation.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33159115","citation_count":71,"is_preprint":false},{"pmid":"17971865","id":"PMC_17971865","title":"Expression of TLR-2, TLR-4, NOD2 and pNF-kappaB in a neonatal rat model of necrotizing enterocolitis.","date":"2007","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/17971865","citation_count":71,"is_preprint":false},{"pmid":"26010811","id":"PMC_26010811","title":"Structure-Activity Relationships of (+)-Naltrexone-Inspired Toll-like Receptor 4 (TLR4) Antagonists.","date":"2015","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26010811","citation_count":70,"is_preprint":false},{"pmid":"22287316","id":"PMC_22287316","title":"Hyaluronan differently modulates TLR-4 and the inflammatory response in mouse chondrocytes.","date":"2012","source":"BioFactors (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22287316","citation_count":70,"is_preprint":false},{"pmid":"17475844","id":"PMC_17475844","title":"Enhanced IL-10 production by TLR4- and TLR2-primed dendritic cells upon TLR restimulation.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17475844","citation_count":70,"is_preprint":false},{"pmid":"22507831","id":"PMC_22507831","title":"Toll-like receptors (TLR2 and TLR4) recognize polysaccharides of Pseudallescheria boydii cell wall.","date":"2012","source":"Carbohydrate research","url":"https://pubmed.ncbi.nlm.nih.gov/22507831","citation_count":63,"is_preprint":false},{"pmid":"22196451","id":"PMC_22196451","title":"Different dimerisation mode for TLR4 upon endosomal acidification?","date":"2011","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/22196451","citation_count":60,"is_preprint":false},{"pmid":"19430824","id":"PMC_19430824","title":"Polymorphisms in Toll-like receptor 4 (TLR4) are associated with protection against leprosy.","date":"2009","source":"European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/19430824","citation_count":60,"is_preprint":false},{"pmid":"30260985","id":"PMC_30260985","title":"Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30260985","citation_count":59,"is_preprint":false},{"pmid":"16024722","id":"PMC_16024722","title":"TLR-4 pathway mediates the inflammatory response but not bacterial elimination in E. coli pneumonia.","date":"2005","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16024722","citation_count":57,"is_preprint":false},{"pmid":"29494148","id":"PMC_29494148","title":"Structure-Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists.","date":"2018","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29494148","citation_count":54,"is_preprint":false},{"pmid":"32225104","id":"PMC_32225104","title":"The Emerging Role of Curcumin in the Modulation of TLR-4 Signaling Pathway: Focus on Neuroprotective and Anti-Rheumatic Properties.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32225104","citation_count":54,"is_preprint":false},{"pmid":"17373355","id":"PMC_17373355","title":"Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria.","date":"2006","source":"The Journal of communicable diseases","url":"https://pubmed.ncbi.nlm.nih.gov/17373355","citation_count":54,"is_preprint":false},{"pmid":"18073092","id":"PMC_18073092","title":"The toll-like receptor-4 (TLR-4) pathway and its possible role in the pathogenesis of Escherichia coli mastitis in dairy cattle.","date":"2007","source":"Veterinary research","url":"https://pubmed.ncbi.nlm.nih.gov/18073092","citation_count":53,"is_preprint":false},{"pmid":"32894580","id":"PMC_32894580","title":"Mycoplasma pneumoniae lipids license TLR-4 for activation of NLRP3 inflammasome and autophagy to evoke a proinflammatory response.","date":"2020","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32894580","citation_count":52,"is_preprint":false},{"pmid":"24499354","id":"PMC_24499354","title":"Toll like receptor (TLR)-4 as a regulator of peripheral endogenous opioid-mediated analgesia in inflammation.","date":"2014","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/24499354","citation_count":49,"is_preprint":false},{"pmid":"31209174","id":"PMC_31209174","title":"Role of Nociceptor Toll-like Receptor 4 (TLR4) in Opioid-Induced Hyperalgesia and Hyperalgesic Priming.","date":"2019","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31209174","citation_count":48,"is_preprint":false},{"pmid":"30177885","id":"PMC_30177885","title":"Schisandrin Attenuates Lipopolysaccharide-Induced Lung Injury by Regulating TLR-4 and Akt/FoxO1 Signaling Pathways.","date":"2018","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30177885","citation_count":48,"is_preprint":false},{"pmid":"28609685","id":"PMC_28609685","title":"Palmitate induces VSMC apoptosis via toll like receptor (TLR)4/ROS/p53 pathway.","date":"2017","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/28609685","citation_count":47,"is_preprint":false},{"pmid":"24339336","id":"PMC_24339336","title":"Modulation of CD14 and TLR4·MD-2 activities by a synthetic lipid A mimetic.","date":"2013","source":"Chembiochem : a European journal of chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/24339336","citation_count":47,"is_preprint":false},{"pmid":"16034104","id":"PMC_16034104","title":"TLR-4 regulates CD8+ T cell trapping in the liver.","date":"2005","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16034104","citation_count":46,"is_preprint":false},{"pmid":"34171331","id":"PMC_34171331","title":"TLR4 biased small molecule modulators.","date":"2021","source":"Pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/34171331","citation_count":45,"is_preprint":false},{"pmid":"31357597","id":"PMC_31357597","title":"LPS-Binding Protein Modulates Acute Renal Fibrosis by Inducing Pericyte-to-Myofibroblast Trans-Differentiation through TLR-4 Signaling.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31357597","citation_count":44,"is_preprint":false},{"pmid":"25417198","id":"PMC_25417198","title":"TLR-4 signalling pathway: MyD88 independent pathway up-regulation in chicken breeds upon LPS treatment.","date":"2014","source":"Veterinary research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25417198","citation_count":43,"is_preprint":false},{"pmid":"24685700","id":"PMC_24685700","title":"TLR4 in Toxoplasmosis; friends or foe?","date":"2014","source":"Microbial pathogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/24685700","citation_count":42,"is_preprint":false},{"pmid":"34771442","id":"PMC_34771442","title":"Interaction of Opioids with TLR4-Mechanisms and Ramifications.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34771442","citation_count":41,"is_preprint":false},{"pmid":"33842587","id":"PMC_33842587","title":"Lactobacillus delbrueckii alleviates depression-like behavior through inhibiting toll-like receptor 4 (TLR4) signaling in mice.","date":"2021","source":"Annals of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33842587","citation_count":41,"is_preprint":false},{"pmid":"35484567","id":"PMC_35484567","title":"Phytochemicals targeting Toll-like receptors 4 (TLR4) in inflammatory bowel disease.","date":"2022","source":"Chinese medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35484567","citation_count":39,"is_preprint":false},{"pmid":"26153766","id":"PMC_26153766","title":"A novel crosstalk between TLR4- and NOD2-mediated signaling in the regulation of intestinal inflammation.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26153766","citation_count":39,"is_preprint":false},{"pmid":"32354122","id":"PMC_32354122","title":"TLR-4 Signaling vs. Immune Checkpoints, miRNAs Molecules, Cancer Stem Cells, and Wingless-Signaling Interplay in Glioblastoma Multiforme-Future Perspectives.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32354122","citation_count":38,"is_preprint":false},{"pmid":"25476977","id":"PMC_25476977","title":"Postulates for validating TLR4 agonists.","date":"2015","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25476977","citation_count":38,"is_preprint":false},{"pmid":"27975098","id":"PMC_27975098","title":"Endotoxaemia-augmented murine venous thrombosis is dependent on TLR-4 and ICAM-1, and potentiated by neutropenia.","date":"2016","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/27975098","citation_count":38,"is_preprint":false},{"pmid":"27714571","id":"PMC_27714571","title":"Correlation of TLR4 and KLF7 in Inflammation Induced by Obesity.","date":"2017","source":"Inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/27714571","citation_count":37,"is_preprint":false},{"pmid":"28978536","id":"PMC_28978536","title":"Role of TLR4 signaling in the nephrotoxicity of heme and heme proteins.","date":"2017","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28978536","citation_count":35,"is_preprint":false},{"pmid":"21457584","id":"PMC_21457584","title":"Genetic variation of TLR-4, TLR-9 and TIRAP genes in Iranian malaria patients.","date":"2011","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/21457584","citation_count":34,"is_preprint":false},{"pmid":"21091668","id":"PMC_21091668","title":"Toll-like receptor (TLR)-4 mediates anti-β2GPI/β2GPI-induced tissue factor expression in THP-1 cells.","date":"2010","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21091668","citation_count":34,"is_preprint":false},{"pmid":"38918327","id":"PMC_38918327","title":"Mechanistic insights on TLR-4 mediated inflammatory pathway in neurodegenerative diseases.","date":"2024","source":"Pharmacological reports : PR","url":"https://pubmed.ncbi.nlm.nih.gov/38918327","citation_count":32,"is_preprint":false},{"pmid":"27930350","id":"PMC_27930350","title":"Toll-Like Receptor (TLR)4 and MyD88 are Essential for Atheroprotection by Peritoneal B1a B Cells.","date":"2016","source":"Journal of the American Heart Association","url":"https://pubmed.ncbi.nlm.nih.gov/27930350","citation_count":31,"is_preprint":false},{"pmid":"31539158","id":"PMC_31539158","title":"TLR4 promotes liver inflammation by activating the JNK pathway.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31539158","citation_count":29,"is_preprint":false},{"pmid":"17100621","id":"PMC_17100621","title":"TLR2 and TLR4 expression during bacterial infections.","date":"2006","source":"Current pharmaceutical design","url":"https://pubmed.ncbi.nlm.nih.gov/17100621","citation_count":28,"is_preprint":false},{"pmid":"30501882","id":"PMC_30501882","title":"Placental inflammation by HMGB1 activation of TLR4 at the syncytium.","date":"2018","source":"Placenta","url":"https://pubmed.ncbi.nlm.nih.gov/30501882","citation_count":28,"is_preprint":false},{"pmid":"35017318","id":"PMC_35017318","title":"Atorvastatin suppresses NLRP3 inflammasome activation in intracerebral hemorrhage via TLR4- and MyD88-dependent pathways.","date":"2022","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/35017318","citation_count":28,"is_preprint":false},{"pmid":"23483583","id":"PMC_23483583","title":"Nitric oxide boosts TLR-4 mediated lipocalin 2 expression in chondrocytes.","date":"2013","source":"Journal of orthopaedic research : official publication of the Orthopaedic Research Society","url":"https://pubmed.ncbi.nlm.nih.gov/23483583","citation_count":27,"is_preprint":false},{"pmid":"27729911","id":"PMC_27729911","title":"Stimulation through CD40 and TLR-4 Is an Effective Host Directed Therapy against Mycobacterium tuberculosis.","date":"2016","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27729911","citation_count":27,"is_preprint":false},{"pmid":"30311146","id":"PMC_30311146","title":"TLR4 Polymorphisms and Expression in Solid Cancers.","date":"2018","source":"Molecular diagnosis & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30311146","citation_count":25,"is_preprint":false},{"pmid":"21841835","id":"PMC_21841835","title":"TLR4 and HMGB1: partners in crime?","date":"2011","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/21841835","citation_count":24,"is_preprint":false},{"pmid":"27856281","id":"PMC_27856281","title":"Adsorbed Fibrinogen stimulates TLR-4 on monocytes and induces BMP-2 expression.","date":"2016","source":"Acta biomaterialia","url":"https://pubmed.ncbi.nlm.nih.gov/27856281","citation_count":23,"is_preprint":false},{"pmid":"33362762","id":"PMC_33362762","title":"TLR4 Response to LPS Is Reinforced by Urokinase Receptor.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33362762","citation_count":22,"is_preprint":false},{"pmid":"38850784","id":"PMC_38850784","title":"Echinatin alleviates inflammation and pyroptosis in hypoxic-ischemic brain damage by inhibiting TLR4/ NF-κB pathway.","date":"2024","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38850784","citation_count":22,"is_preprint":false},{"pmid":"27265821","id":"PMC_27265821","title":"Imidacloprid induced histomorphological changes and expression of TLR-4 and TNFα in lung.","date":"2016","source":"Pesticide biochemistry and physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27265821","citation_count":22,"is_preprint":false},{"pmid":"33139717","id":"PMC_33139717","title":"Resveratrol attenuates TLR-4 mediated inflammation and elicits therapeutic potential in models of sepsis.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33139717","citation_count":20,"is_preprint":false},{"pmid":"22267982","id":"PMC_22267982","title":"TLR-4 expression and decrease in chronic inflammation: indicators of aggressive follicular thyroid carcinoma.","date":"2012","source":"Journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22267982","citation_count":20,"is_preprint":false},{"pmid":"26695933","id":"PMC_26695933","title":"Comparison of TLR-2, TLR-4, and antimicrobial peptide levels in different lesions of acne vulgaris.","date":"2015","source":"Cutaneous and ocular toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/26695933","citation_count":19,"is_preprint":false},{"pmid":"24878008","id":"PMC_24878008","title":"TLR-2 and TLR-4 expression in monocytes of newborns with late-onset sepsis.","date":"2014","source":"Jornal de pediatria","url":"https://pubmed.ncbi.nlm.nih.gov/24878008","citation_count":18,"is_preprint":false},{"pmid":"33907855","id":"PMC_33907855","title":"Non-toxic sulfur inhibits LPS-induced inflammation by regulating TLR-4 and JAK2/STAT3 through IL-6 signaling.","date":"2021","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/33907855","citation_count":18,"is_preprint":false},{"pmid":"35691508","id":"PMC_35691508","title":"Cyanidin and delphinidin restore colon physiology in high fat diet-fed mice: Involvement of TLR-4 and redox-regulated signaling.","date":"2022","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35691508","citation_count":18,"is_preprint":false},{"pmid":"27054952","id":"PMC_27054952","title":"Hyaluronan Inhibits Tlr-4-Dependent RANKL Expression in Human Rheumatoid Arthritis Synovial Fibroblasts.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27054952","citation_count":18,"is_preprint":false},{"pmid":"36721803","id":"PMC_36721803","title":"Toll-Like Receptor 4 (TLR4) and AMPK Relevance in Cardiovascular Disease.","date":"2021","source":"Advanced pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/36721803","citation_count":17,"is_preprint":false},{"pmid":"29775649","id":"PMC_29775649","title":"Expression and function of TLR4- induced B1R bradykinin receptor on cardiac fibroblasts.","date":"2018","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29775649","citation_count":17,"is_preprint":false},{"pmid":"37218423","id":"PMC_37218423","title":"Concomitant inhibition of TLR-4 and SGLT2 by phloretin and empagliflozin prevents diabetes-associated ischemic acute kidney injury.","date":"2023","source":"Food & function","url":"https://pubmed.ncbi.nlm.nih.gov/37218423","citation_count":17,"is_preprint":false},{"pmid":"24719374","id":"PMC_24719374","title":"Interactions of surface-expressed TLR-4 and endosomal TLR-9 accelerate lupus progression in anti-dsDNA antibody transgenic mice.","date":"2014","source":"Experimental biology and medicine (Maywood, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/24719374","citation_count":17,"is_preprint":false},{"pmid":"31229737","id":"PMC_31229737","title":"TLR-2 and TLR-4 agonists favor expansion of CD4+ T cell subsets implicated in the severity of neuromyelitis optica spectrum disorders.","date":"2019","source":"Multiple sclerosis and related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/31229737","citation_count":17,"is_preprint":false},{"pmid":"30113863","id":"PMC_30113863","title":"Influence of morphine on TLR4/ NF-kB signaling pathway of MCF-7 cells.","date":"2018","source":"Bratislavske lekarske listy","url":"https://pubmed.ncbi.nlm.nih.gov/30113863","citation_count":17,"is_preprint":false},{"pmid":"32654051","id":"PMC_32654051","title":"The relationship among vitamin D, TLR4 pathway and preeclampsia.","date":"2020","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/32654051","citation_count":16,"is_preprint":false},{"pmid":"19277200","id":"PMC_19277200","title":"Toll-like receptor 4 (TLR4) and typhoid fever in Vietnam.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19277200","citation_count":16,"is_preprint":false},{"pmid":"33090488","id":"PMC_33090488","title":"Scoparone alleviates hepatic fibrosis by inhibiting the TLR-4/NF-κB pathway.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33090488","citation_count":16,"is_preprint":false},{"pmid":"32094226","id":"PMC_32094226","title":"Tristetraprolin regulates necroptosis during tonic Toll-like receptor 4 (TLR4) signaling in murine macrophages.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32094226","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52954,"output_tokens":7107,"usd":0.132734,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16097,"output_tokens":7091,"usd":0.12888,"stage2_stop_reason":"end_turn"},"total_usd":0.261614,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"TLR4 (hToll) signals through the adaptor protein MyD88, which in turn activates the kinase IRAK and the TRAF6 protein to activate NF-κB; AP-1 activation differs from IL-1R signaling, establishing MyD88 as a general adaptor for the Toll/IL-1R family.\",\n      \"method\": \"Dominant-negative and overexpression constructs in cell transfection assays; epistasis between hToll, MyD88, IRAK, and TRAF6 measured by NF-κB reporter assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean epistasis/genetic dissection with multiple pathway components replicated across labs; foundational paper widely confirmed\",\n      \"pmids\": [\"9734363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"TLR4 was identified by positional cloning as the central component of the mammalian LPS receptor, establishing it as the endotoxin sensor responsible for LPS-induced innate immune signaling.\",\n      \"method\": \"Positional cloning in LPS-hyporesponsive mouse mutants; gene knockout studies\",\n      \"journal\": \"Current topics in microbiology and immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — positional cloning plus knockout corroboration, independently replicated across multiple laboratories\",\n      \"pmids\": [\"12467247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TAK-242 (resatorvid) binds selectively to TLR4 at Cys747 in the intracellular domain and disrupts protein-protein interactions between TLR4 and its adaptor molecules TIRAP and TRAM, thereby inhibiting both MyD88-dependent (NF-κB) and TRIF-dependent (ISRE) signaling pathways.\",\n      \"method\": \"Co-immunoprecipitation in HEK293 cells overexpressing TLR4/MD-2 with TIRAP or TRAM; NF-κB and ISRE reporter assays; IRAK activation assay in RAW264.7 cells\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP combined with functional reporter assays and endogenous kinase activation measurement in a single rigorous study\",\n      \"pmids\": [\"20881006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"HMGB1 signals through TLR4 (and TLR2) to induce cytokine production; in primary macrophages from TLR4 and MyD88 knockout mice, HMGB1-induced TNF release is significantly reduced compared to wild-type controls, placing TLR4/MyD88 in the HMGB1 signaling pathway.\",\n      \"method\": \"Neutralizing anti-TLR4/TLR2 antibodies in human whole blood and primary macrophages; TNF/IL-8 cytokine measurements; knockout macrophages (TLR4-/-, MyD88-/-, TLR2-/-); TLR2/TLR4-transfected HEK293 cells\",\n      \"journal\": \"Shock (Augusta, Ga.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockout plus antibody blocking plus transfection, but differential results between cell types add complexity\",\n      \"pmids\": [\"16878026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MyD88 associates with PI3K p85 via a YXXM motif in the MyD88 TIR domain; sustained interaction of the MyD88/PI3K complex with the TLR4 intracellular signaling platform negatively regulates TLR4 signaling. LPS-induced Akt phosphorylation is TLR4-dependent and MyD88-dependent.\",\n      \"method\": \"Co-immunoprecipitation of MyD88 variants (YXXM→YXXA, TIR-domain deletion, death-domain deletion) with p85, TLR4, and WT MyD88; Akt phosphorylation assays in wild-type vs. MyD88-/- macrophages\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP with structure-function mutagenesis in single lab, supported by knockout confirmation\",\n      \"pmids\": [\"19289601\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"FoxO1 transcription factor binds to multiple enhancer-like elements within the Tlr4 gene itself and in Tlr4 pathway genes, promoting Tlr4 expression and macrophage inflammatory signaling; TLR4 activation in turn induces AKT which inactivates FoxO1, establishing a self-limiting inflammatory loop.\",\n      \"method\": \"ChIP-Seq to identify FoxO1 binding sites; FoxO1 knockout/knockdown macrophage studies; reporter and cytokine secretion assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-Seq plus functional KO/KD with cytokine readouts in single lab\",\n      \"pmids\": [\"21045807\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TLR4 initiates distinct signaling pathways depending on cellular location: at the plasma membrane, bridging factor Mal recruits MyD88 leading to proinflammatory cytokine production; upon internalization into endosomes, TLR4 uses TRAM as a bridging factor to activate the MyD88-independent/TRIF pathway leading to type I interferon expression.\",\n      \"method\": \"Analysis of crystal structure data (TLR3-dsRNA complex used as model), combined with published biochemical and cell biology evidence reviewed and synthesized; pH-sensitivity experiments and adaptor localization data\",\n      \"journal\": \"Trends in biochemical sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — mechanistic model integrating published structural and cell biology data; the TLR4 dual-location signaling mechanism itself is supported by multiple independent studies cited herein\",\n      \"pmids\": [\"22196451\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HMGB1 acts via TLR4 (but not RAGE) to accelerate muscle fatigue by impairing sarcoplasmic reticulum Ca2+ release in skeletal muscle fibers; signaling requires HMGB1 with a reduced Cys106 and a disulfide bond between Cys23 and Cys45.\",\n      \"method\": \"Single intact muscle fiber preparations from wild-type, TLR4-/-, and RAGE-/- mice; Ca2+ measurements during tetanic contractions; recombinant HMGB1 with defined redox states; immunofluorescence and confocal microscopy for TLR4 and MHC-I co-expression\",\n      \"journal\": \"Annals of the rheumatic diseases\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — TLR4-/- vs. RAGE-/- genetic dissection with quantitative functional readout plus redox-state requirement of ligand defined in single rigorous study\",\n      \"pmids\": [\"23148306\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The TLR4-MD-2 complex recognizes LPS in a cascade involving LBP and CD14; structural studies show how the TLR4/MD-2 complex forms a 2:2:2 (TLR4:MD-2:LPS) activated homodimer, with Arg241 of TLR4 and Tyr102, Ser120, Lys122 of MD-2 important for antagonist binding.\",\n      \"method\": \"Crystal structure analysis of TLR4/MD-2/LPS complexes; structural basis reviewed from published crystal structures\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with structural validation of key residues; independently replicated in multiple structural labs\",\n      \"pmids\": [\"24310172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"A synthetic monosaccharide lipid A mimetic (compound 3) directly binds the MD-2 co-receptor (confirmed by NMR and molecular modeling) and also interacts with CD14, stimulating its internalization; dual targeting of MD-2 and CD14 inhibits TLR4 signaling, with greater effect at low LPS concentration when CD14 is important.\",\n      \"method\": \"NMR spectroscopy of compound-MD-2 interaction; molecular modeling/docking; CD14 internalization assay; TLR4 signaling inhibition in HEK-blue cells and murine macrophages\",\n      \"journal\": \"Chembiochem : a European journal of chemical biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR-confirmed binding plus functional cell assays in single lab\",\n      \"pmids\": [\"24339336\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Constitutively active TLR4 (CD4/hTLR4 chimera) activates an NF-κB reporter in cardiac myocytes but does not activate AP-1 or iNOS reporter constructs; TLR4 expression in cardiac myocytes is enhanced by LPS or IL-1β, an effect inhibited by the antioxidant PDTC.\",\n      \"method\": \"Transfection of constitutively active TLR4 construct with NF-κB, AP-1, and iNOS reporter constructs in cardiac myocytes; LPS/IL-1β stimulation; PDTC inhibition\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assays with constitutively active construct, clean negative results for AP-1/iNOS, pharmacological inhibition\",\n      \"pmids\": [\"10430608\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TLR4 activation promotes cardiomyocyte apoptosis through a pathway involving decreased SIRT2 expression, increased p53 acetylation, and activation of caspase-7 and caspase-9; TLR4 overexpression in H9c2 cells recapitulates nuclear p53 translocation and mitochondrial dysfunction.\",\n      \"method\": \"LPS treatment of rats (osmotic pump) and H9c2 cells; TLR4 and SIRT2 cDNA overexpression; Western blotting for p53 acetylation, cleaved caspase-7/caspase-9; mitochondrial complex activity assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo and in vitro corroboration with overexpression and pathway protein measurements, single lab\",\n      \"pmids\": [\"33159115\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"During TLR4 signaling, necrosome activation in macrophages is mediated through both MyD88 and TRIF adaptor proteins and is inhibited by MK2; the RNA-binding protein tristetraprolin (TTP/ZFP36) inhibits TNFα/JNK-induced necrosome signaling during tonic TLR4 stimulation, preventing necroptosis.\",\n      \"method\": \"LPS stimulation of macrophages from WT, MyD88-/-, Trif-/-, MyD88-/-Trif-/-, MK2-/-, and Zfp36-/- mice; immunoblotting for necrosome components; ELISA for cytokines; cell death assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic knockouts with orthogonal readouts (necrosome, cytokine, cell death) in systematic comparison\",\n      \"pmids\": [\"32094226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TLR4 activation by LPS abolishes cAMP-induced UCP1 upregulation in primary human adipocytes via endoplasmic reticulum stress; silencing of CHOP (a downstream ER stress mediator) or chemical chaperone treatment reverses LPS-induced suppression of adaptive thermogenesis, placing TLR4 upstream of ER stress/CHOP in suppressing UCP1 expression.\",\n      \"method\": \"LPS and high-fat diet treatment in vivo; siRNA-mediated TLR4 silencing; CHOP knockout mice; chemical chaperone treatment; UCP1 expression assays in primary human adipocytes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic (CHOP KO, TLR4 siRNA) plus pharmacological intervention with functional thermogenesis readout, single lab\",\n      \"pmids\": [\"26370079\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"uPAR (urokinase receptor) is a component of the TLR4 interactome; uPAR co-localizes and interacts with TLR4 on the cell membrane along with scavenger receptor CD36; downregulation of uPAR diminishes LPS-induced TLR4 signaling and NF-κB activation in myeloid and non-myeloid cells, and uPAR-/- mice show reduced inflammatory response in polymicrobial sepsis.\",\n      \"method\": \"Co-localization and co-immunoprecipitation of uPAR with TLR4 and CD36; uPAR knockdown in vitro; uPAR-/- mice in cecal ligation and puncture sepsis model; NFκB activation and cytokine assays\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP binding evidence plus in vivo KO confirmation, single lab\",\n      \"pmids\": [\"33362762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In nociceptors, TLR4 mediates opioid-induced hyperalgesia (OIH) and hyperalgesic priming induced by low-dose morphine; antisense knockdown of TLR4 in nociceptors prevented OIH and priming; this mechanism requires PKCε signaling downstream of TLR4. High-dose morphine-induced analgesia and priming are TLR4-independent.\",\n      \"method\": \"Intrathecal antisense oligodeoxynucleotide (AS-ODN) to TLR4 mRNA; PKCε AS-ODN; saporin-based nociceptor depletion; nociceptive threshold measurements in rats\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — antisense knockdown with clean nociceptive functional readout, multiple negative controls confirming specificity\",\n      \"pmids\": [\"31209174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TLR4 activation by LPS in macrophages causes significant subcellular lipidome remodeling across multiple organelles: ceramide and cholesterol precursors (desmosterol, lanosterol) increase in all compartments; oxidized sterols increase and unsaturated cardiolipins decrease in mitochondria; unsaturated ether-linked phosphatidylethanolamines decrease in the ER.\",\n      \"method\": \"Subcellular fractionation (nuclei, mitochondria, ER, plasmalemma, cytoplasm) of RAW264.7 macrophages; liquid chromatography/tandem mass spectrometry lipidomics of 229 lipid species\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic organelle fractionation with quantitative lipidomics, single lab\",\n      \"pmids\": [\"20574076\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TLR4 and MyD88 expressed on peritoneal B1a B cells are required for their natural IgM secretion and atheroprotective function; adoptive transfer of TLR4-/- or MyD88-/- B1a cells failed to suppress atherosclerosis, reduce lesion apoptotic cells, or modulate T-cell infiltrates in ApoE-/- mice.\",\n      \"method\": \"Adoptive transfer of WT, TLR4-/-, TLR2-/-, TLR9-/-, or MyD88-/- B1a cells into splenectomized ApoE-/- mice fed high-fat diet; atherosclerosis quantification; IgM ELISA; immunohistochemistry of lesions\",\n      \"journal\": \"Journal of the American Heart Association\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic dissection with adoptive transfer and multiple functional endpoints, single lab\",\n      \"pmids\": [\"27930350\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Adsorbed fibrinogen interacts with TLR4 on human monocytes, triggering ERK1/2 and JNK MAPK activation (but not p38) and inducing BMP-2 production; pharmacological TLR4 inhibition reduces both ERK/JNK phosphorylation and BMP-2 expression, establishing TLR4 as the upstream receptor for this pro-osteogenic pathway.\",\n      \"method\": \"Flow cytometry for TLR4 cell surface expression; Western blot for MAPK phosphorylation; specific TLR4 pharmacological inhibitor; BMP-2 mRNA and protein measurement in primary human monocytes on fibrinogen-coated chitosan substrates\",\n      \"journal\": \"Acta biomaterialia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological inhibition with multiple downstream readouts, single lab\",\n      \"pmids\": [\"27856281\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"LPS/TLR4 signaling regulates osteoclastogenesis independent of the RANKL/RANK/OPG axis; TLR4 inhibitor TAK-242 blocks LPS-induced osteoclast differentiation and TNF-α secretion, and the pathway operates through LPS/TLR4/TNF-α/TNFR-2 autocrine/paracrine signaling.\",\n      \"method\": \"RAW264.7 differentiation assays; TAK-242 TLR4 inhibition; anti-TNF-α antibody blocking; membrane TLR4 and TNFR-2 level measurement; RANKL-primed then LPS-treated experimental design\",\n      \"journal\": \"BMC immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological inhibition plus antibody blocking with functional osteoclast differentiation and cytokine readouts, single lab\",\n      \"pmids\": [\"33765924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TLR4 mediates acute heme-induced renal vasoconstriction; heme activates NF-κB and MCP-1 expression in renal epithelial cells via TLR4 signaling (blocked by TAK-242), but TLR4 does not mediate the anti-inflammatory Nrf2/HO-1 response to heme and does not mediate major mechanisms of glycerol-induced heme protein AKI.\",\n      \"method\": \"TAK-242 TLR4 antagonist in vivo; TLR4+/+ vs. TLR4-/- mice; renal blood flow measurement; NF-κB and Nrf2 reporter assays in renal epithelial cells; glycerol AKI model\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO plus pharmacological inhibition with multiple endpoints, important positive and negative findings dissected\",\n      \"pmids\": [\"28978536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TLR4 is required for in vivo trapping of activated CD8+ T cells in the liver; in TLR4-deficient mice, the liver is compromised in its ability to sequester activated CD8+ T cells, revealing a role for basal TLR4 signaling by commensal LPS in regulating T cell distribution.\",\n      \"method\": \"TLR4-deficient mice (basal conditions, no exogenous inflammation); flow cytometry quantification of activated CD8+ T cells in liver vs. circulation; correlation analysis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean in vivo genetic loss-of-function with defined cellular phenotype, single lab\",\n      \"pmids\": [\"16034104\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TLR4 activation induces B1 bradykinin receptor (B1R) expression in cardiac fibroblasts via upregulation of B1R mRNA and protein; LPS-primed cardiac fibroblasts show enhanced DAKD (B1R agonist)-induced PGI2 secretion and NO production and reduced collagen I levels, revealing TLR4-B1R crosstalk in cardiac inflammation.\",\n      \"method\": \"qRT-PCR and Western blot for B1R, COX-2, iNOS in primary human, rat, and mouse cardiac fibroblasts; LPS pretreatment; DAKD stimulation; PGI2 and NO measurement\",\n      \"journal\": \"Toxicology and applied pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multi-species corroboration with functional signaling readouts, single lab\",\n      \"pmids\": [\"29775649\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TLR4 ligand (LPS/Kdo2-lipid A) synergizes with sustained Ca2+ influx to activate the 5-lipoxygenase (5-LO) eicosanoid pathway in macrophages, independent of NF-κB-mediated protein synthesis; COX metabolite profiles are unaffected by TLR stimulation alone.\",\n      \"method\": \"LC/MS-MS quantification of >60 eicosanoids in RAW264.7 macrophages stimulated with 16 agonists; NF-κB inhibition to dissect protein synthesis-dependent vs. -independent pathways; Ca2+ influx manipulation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — quantitative mass spectrometry-based eicosanoid profiling with pharmacological dissection, single lab\",\n      \"pmids\": [\"17535806\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TLR4 mediates anti-β2GPI/β2GPI-induced tissue factor (TF) expression in THP-1 monocytic cells; both TLR4 and annexin A2 (ANX2) can bind β2GPI, and ANX2-RNAi knockdown diminishes TLR4, MD-2, MyD88, and TF expression in response to the complex, revealing cooperative ANX2-TLR4 signaling.\",\n      \"method\": \"β2GPI affinity column pulldown showing TLR4 and ANX2 binding; ANX2-specific RNAi lentivirus knockdown; Western blot for TLR4/MD-2/MyD88/TF; paclitaxel competition with MD-2 ligand\",\n      \"journal\": \"Clinical and experimental immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pulldown binding plus RNAi loss-of-function with downstream signaling readouts, single lab\",\n      \"pmids\": [\"21091668\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TLR4-dependent activation of the JNK signaling pathway promotes APAP-induced liver inflammation; TLR4-/- mice show attenuated JNK phosphorylation, reduced inflammatory cytokines, and less macrophage/neutrophil infiltration after acetaminophen challenge; TLR4 siRNA in RAW264.7 cells similarly inhibits JNK and p38 phosphorylation.\",\n      \"method\": \"TLR4-/- vs. WT mice treated with APAP; liver histology, ALT/GSH measurement; RT-qPCR and ELISA for cytokines; Western blot for phospho-JNK and phospho-p38; flow cytometry for immune cell infiltration; TLR4-siRNA in RAW264.7\",\n      \"journal\": \"European review for medical and pharmacological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with in vitro siRNA corroboration and multiple signaling readouts, single lab\",\n      \"pmids\": [\"31539158\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TLR4 functions as a transmembrane pattern-recognition receptor that detects LPS and other danger-associated ligands by forming a complex with the co-receptor MD-2 and accessory proteins CD14 and LBP, leading to an activated (TLR4:MD-2:LPS)2 homodimer; at the plasma membrane TLR4 recruits the bridging adaptor Mal to engage MyD88, activating IRAK and TRAF6 to drive NF-κB and MAPK signaling, while after endosomal internalization it switches to TRAM-dependent TRIF signaling to induce type I interferons; the small-molecule TAK-242 binds Cys747 in the intracellular domain and disrupts TLR4–TIRAP and TLR4–TRAM interactions; PI3K/p85 associates with the MyD88 YXXM motif and negatively regulates signaling; TLR4 also couples to additional interactors including uPAR/CD36, and activates cell-type-specific downstream effectors including JNK, PKCε, SIRT2/p53, and ER stress/CHOP to mediate inflammation, apoptosis, and thermogenesis suppression.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TLR4 is the central transmembrane pattern-recognition receptor of the mammalian innate immune system, identified by positional cloning as the sensor responsible for LPS-induced signaling [#1]. Ligand detection occurs through the TLR4–MD-2 co-receptor complex, which recognizes LPS in a cascade involving LBP and CD14 and assembles into an activated 2:2:2 (TLR4:MD-2:LPS) homodimer, with defined residues governing agonist/antagonist binding [#8, #9]. Once engaged, TLR4 signals through bifurcated, location-dependent adaptor circuitry: at the plasma membrane the bridging factor Mal recruits MyD88 to activate IRAK and TRAF6, driving NF-κB activation, whereas upon endosomal internalization TLR4 switches to a TRAM-bridged, MyD88-independent TRIF pathway to induce type I interferons [#0, #6]. This adaptor logic is targetable: the small molecule TAK-242 binds Cys747 in the TLR4 intracellular domain and disrupts both the TLR4–TIRAP and TLR4–TRAM interactions, blocking MyD88- and TRIF-dependent outputs [#2], and signaling is intrinsically restrained by a MyD88–PI3K(p85) complex docking on the YXXM motif of MyD88 [#4] and by a FoxO1–AKT feedback loop that controls Tlr4 transcription [#5]. Beyond endotoxin, TLR4 senses endogenous danger ligands including HMGB1 (in a redox-state-dependent manner) and fibrinogen, and cooperates with accessory partners such as uPAR/CD36 and annexin A2 to amplify inflammatory responses [#3, #7, #14, #18, #24]. Downstream of these inputs TLR4 engages cell-type-specific effectors—JNK/p38 MAPK in hepatic and monocytic inflammation [#18, #25], necrosome assembly via both MyD88 and TRIF [#12], a SIRT2/p53/caspase apoptotic axis in cardiomyocytes [#11], and ER stress/CHOP signaling that suppresses adaptive thermogenesis [#13]—thereby mediating inflammation, programmed cell death, and metabolic adaptation across diverse tissues.\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established the core adaptor logic of TLR4 by placing MyD88, IRAK, and TRAF6 downstream of the receptor, defining how an innate receptor converts ligand sensing into NF-κB activation.\",\n      \"evidence\": \"Dominant-negative and overexpression epistasis with NF-κB reporters in transfected cells\",\n      \"pmids\": [\"9734363\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the physiological ligand\", \"AP-1 activation mechanism left distinct from IL-1R but undefined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identified TLR4 itself as the LPS receptor, answering what molecule senses endotoxin and anchoring TLR4 as the endotoxin sensor of innate immunity.\",\n      \"evidence\": \"Positional cloning of LPS-hyporesponsive mouse mutants plus knockout corroboration\",\n      \"pmids\": [\"12467247\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the structural basis of LPS recognition\", \"Role of co-receptors not defined here\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Revealed a homeostatic, non-inflammatory role for basal TLR4 signaling by commensal LPS in distributing activated T cells, broadening TLR4 function beyond acute pathogen response.\",\n      \"evidence\": \"TLR4-deficient mice under basal conditions with flow-cytometric quantification of hepatic CD8+ T-cell trapping\",\n      \"pmids\": [\"16034104\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Adaptor/effector pathway for T-cell trapping unidentified\", \"Single phenotype, single lab\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Extended TLR4 ligand recognition to the endogenous danger signal HMGB1, establishing TLR4/MyD88 as a sensor of sterile injury, not only microbial LPS.\",\n      \"evidence\": \"Knockout macrophages, neutralizing antibodies, and transfected HEK293 cells with cytokine readouts\",\n      \"pmids\": [\"16878026\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Differential results between cell types complicate interpretation\", \"Direct HMGB1–TLR4 binding not demonstrated here\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showed TLR4 can drive lipid-mediator (5-LO eicosanoid) output independently of NF-κB-driven protein synthesis when combined with Ca2+ influx, revealing a transcription-independent arm of TLR4 signaling.\",\n      \"evidence\": \"LC/MS-MS eicosanoid profiling with NF-κB inhibition and Ca2+ manipulation in RAW264.7 macrophages\",\n      \"pmids\": [\"17535806\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular link from TLR4 to 5-LO activation unmapped\", \"Requires synergistic Ca2+ signal of undefined source\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined a built-in negative-regulatory mechanism whereby a MyD88–PI3K(p85) complex docks via the MyD88 YXXM motif to restrain TLR4 output, addressing how signaling is self-limited.\",\n      \"evidence\": \"Reciprocal Co-IP with MyD88 structure-function mutants plus Akt phosphorylation in MyD88-/- macrophages\",\n      \"pmids\": [\"19289601\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Quantitative contribution to signal damping in vivo unclear\", \"Single lab\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Resolved how a single inhibitor blocks both TLR4 outputs: TAK-242 binds Cys747 and disrupts TLR4–TIRAP and TLR4–TRAM interactions, pinpointing an intracellular druggable site.\",\n      \"evidence\": \"Reciprocal Co-IP in HEK293, NF-κB/ISRE reporters, and IRAK activation in RAW264.7\",\n      \"pmids\": [\"20881006\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural detail of the Cys747 binding pocket not solved here\", \"Selectivity across TLR family not fully mapped\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified a transcriptional feed-forward/feedback loop in which FoxO1 promotes Tlr4 expression while TLR4-induced AKT inactivates FoxO1, explaining self-limiting macrophage inflammation.\",\n      \"evidence\": \"ChIP-Seq of FoxO1 binding plus FoxO1 KO/KD macrophage cytokine assays\",\n      \"pmids\": [\"21045807\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct demonstration of loop dynamics in vivo limited\", \"Single lab\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Articulated the spatial bifurcation of TLR4 signaling—Mal/MyD88 at the membrane versus TRAM/TRIF in endosomes—explaining how one receptor produces both cytokines and type I interferons.\",\n      \"evidence\": \"Synthesis of structural and cell-biology data including adaptor localization and pH-sensitivity\",\n      \"pmids\": [\"22196451\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Integrative model rather than single primary dataset\", \"Trafficking machinery driving the switch not detailed here\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Provided the structural mechanism of LPS recognition, showing the TLR4/MD-2/LPS 2:2:2 activated homodimer and the residues governing agonist/antagonist binding.\",\n      \"evidence\": \"Crystal structure analysis of TLR4/MD-2/LPS complexes\",\n      \"pmids\": [\"24310172\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dynamics of dimerization in membranes not captured\", \"Co-receptor CD14/LBP handoff geometry not resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrated druggable dual targeting of the recognition module by a lipid A mimetic that binds MD-2 and engages CD14, defining co-receptor-level antagonism.\",\n      \"evidence\": \"NMR of compound–MD-2 binding, docking, CD14 internalization, and TLR4 signaling inhibition in HEK-blue and macrophages\",\n      \"pmids\": [\"24339336\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo efficacy not established\", \"Single lab\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Linked redox-defined HMGB1 to TLR4 in a non-immune tissue, showing TLR4 (not RAGE) drives muscle fatigue via impaired SR Ca2+ release, expanding TLR4 effector outputs beyond cytokines.\",\n      \"evidence\": \"Single intact muscle fibers from TLR4-/- vs. RAGE-/- mice with Ca2+ measurements and defined HMGB1 redox states\",\n      \"pmids\": [\"23148306\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Intracellular pathway from TLR4 to SR Ca2+ handling unmapped\", \"Adaptor usage in muscle not defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined how TLR4 controls regulated necroptosis, showing necrosome activation through both MyD88 and TRIF and its restraint by MK2 and the RNA-binding protein TTP/ZFP36.\",\n      \"evidence\": \"LPS stimulation across WT, MyD88-/-, Trif-/-, double-KO, MK2-/-, and Zfp36-/- macrophages with necrosome, cytokine, and cell-death readouts\",\n      \"pmids\": [\"32094226\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise molecular target of TTP within the necrosome pathway not pinpointed\", \"Relevance in vivo not tested here\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Connected TLR4 to metabolic suppression of thermogenesis, placing TLR4 upstream of ER stress/CHOP in blocking cAMP-induced UCP1 in adipocytes.\",\n      \"evidence\": \"LPS/HFD in vivo, TLR4 siRNA, CHOP KO mice, and chemical chaperone with UCP1 readouts\",\n      \"pmids\": [\"26370079\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Adaptor route from TLR4 to ER stress not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified a TLR4-driven apoptotic axis in cardiomyocytes operating through SIRT2 loss, p53 acetylation, and caspase activation, defining a cell-death effector branch.\",\n      \"evidence\": \"LPS in rats and H9c2 cells with TLR4/SIRT2 overexpression and pathway protein blotting\",\n      \"pmids\": [\"33159115\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Link between TLR4 proximal signaling and SIRT2 regulation unmapped\", \"Single lab\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Placed uPAR (with CD36) in the TLR4 membrane interactome as a positive regulator of LPS-induced NF-κB signaling and sepsis inflammation.\",\n      \"evidence\": \"Co-localization/Co-IP of uPAR with TLR4 and CD36, uPAR knockdown, and uPAR-/- mice in CLP sepsis\",\n      \"pmids\": [\"33362762\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding interface not defined\", \"Mechanism of signal enhancement unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showed TLR4 cooperates with annexin A2 to sense the anti-β2GPI/β2GPI complex and drive tissue factor expression, expanding the receptor's prothrombotic ligand repertoire.\",\n      \"evidence\": \"β2GPI affinity pulldown of TLR4 and ANX2 with ANX2-RNAi and TLR4/MD-2/MyD88/TF blotting in THP-1 cells\",\n      \"pmids\": [\"21091668\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Stoichiometry of TLR4–ANX2 cooperation unknown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Mapped TLR4-induced organelle-resolved lipidome remodeling, revealing that activation reshapes sterol, ceramide, cardiolipin, and ether-lipid pools across compartments.\",\n      \"evidence\": \"Subcellular fractionation and LC-MS/MS lipidomics of 229 species in RAW264.7 macrophages\",\n      \"pmids\": [\"20574076\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal signaling link from TLR4 to specific lipid changes not established\", \"Functional consequence per organelle unclear\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Showed in cardiac myocytes that constitutively active TLR4 activates NF-κB but not AP-1 or iNOS, demonstrating cell-type-specific selectivity of TLR4 transcriptional outputs.\",\n      \"evidence\": \"Constitutively active TLR4 chimera with NF-κB/AP-1/iNOS reporters and PDTC inhibition in cardiac myocytes\",\n      \"pmids\": [\"10430608\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Basis for restricted AP-1/iNOS activation undefined\", \"Reliant on chimeric construct\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrated a protective TLR4/MyD88 function in B1a B cells required for natural IgM secretion and atheroprotection, illustrating context-dependent beneficial roles.\",\n      \"evidence\": \"Adoptive transfer of WT vs. TLR4-/-/MyD88-/- B1a cells into ApoE-/- mice with lesion and IgM endpoints\",\n      \"pmids\": [\"27930350\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Ligand driving B1a TLR4 function unidentified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified adsorbed fibrinogen as a TLR4 ligand on monocytes driving ERK/JNK MAPK activation and BMP-2 production, linking TLR4 to a pro-osteogenic response.\",\n      \"evidence\": \"Flow cytometry, MAPK phospho-blotting, TLR4 pharmacological inhibition, and BMP-2 measurement in human monocytes\",\n      \"pmids\": [\"27856281\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct fibrinogen–TLR4 binding not biochemically resolved\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined a TLR4/PKCε pathway in nociceptors mediating opioid-induced hyperalgesia and priming, distinguishing low-dose from high-dose morphine mechanisms.\",\n      \"evidence\": \"Intrathecal TLR4 and PKCε antisense oligonucleotides with nociceptive threshold readouts in rats\",\n      \"pmids\": [\"31209174\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous TLR4 ligand in OIH unidentified\", \"Adaptor usage in nociceptors not defined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed TLR4 drives acetaminophen-induced liver inflammation via JNK activation, defining a MAPK effector branch in sterile hepatic injury.\",\n      \"evidence\": \"TLR4-/- vs. WT mice with histology, cytokine, and phospho-JNK/p38 readouts plus TLR4 siRNA in RAW264.7\",\n      \"pmids\": [\"31539158\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Proximal ligand/adaptor coupling to JNK not delineated\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated TLR4 mediates acute heme-induced renal vasoconstriction and NF-κB/MCP-1 induction while sparing the Nrf2/HO-1 axis, dissecting which heme responses depend on TLR4.\",\n      \"evidence\": \"TAK-242 in vivo, TLR4-/- mice, renal blood flow, and NF-κB/Nrf2 reporters in renal epithelial cells\",\n      \"pmids\": [\"28978536\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of heme engagement of TLR4 unresolved\", \"Does not mediate glycerol-induced AKI\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showed TLR4 induces B1 bradykinin receptor expression in cardiac fibroblasts, revealing TLR4–B1R crosstalk modulating PGI2, NO, and collagen in cardiac inflammation.\",\n      \"evidence\": \"qRT-PCR/Western blot for B1R/COX-2/iNOS with LPS priming and DAKD stimulation across human, rat, and mouse fibroblasts\",\n      \"pmids\": [\"29775649\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Signaling route from TLR4 to B1R transcription unmapped\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the spatial adaptor switch is physically controlled by trafficking machinery, and how diverse endogenous ligands (HMGB1, fibrinogen, heme, β2GPI complexes) are differentially read to select cell-type-specific effector branches (JNK, SIRT2/p53, ER stress/CHOP, PKCε), remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified mechanism linking ligand identity to downstream effector selection\", \"Trafficking determinants of the MyD88-to-TRIF switch not biochemically defined\", \"Many tissue-specific effector branches rest on single-lab studies\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0001618\", \"supporting_discovery_ids\": [1, 8]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 1, 8]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [8, 9]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [6, 14]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 1, 8, 12]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 2, 6]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [11, 12]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"complexes\": [\"TLR4:MD-2:LPS activated homodimer\"],\n    \"partners\": [\"MD2 (LY96)\", \"CD14\", \"MyD88\", \"TIRAP\", \"TRAM (TICAM2)\", \"PIK3R1\", \"uPAR (PLAUR)\", \"CD36\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}